269 related articles for article (PubMed ID: 31531758)
1. The Dilemma of Resuming Antithrombotic Therapy After Intracranial Hemorrhage in Patients With Left Ventricular Assist Devices.
Santos CD; Matos NL; Asleh R; Dawit S; Rabinstein AA; O'Carroll CB; Li Z; Freeman WD
Neurocrit Care; 2020 Jun; 32(3):822-827. PubMed ID: 31531758
[TBL] [Abstract][Full Text] [Related]
2. Reversal and Resumption of Antithrombotic Therapy in LVAD-Associated Intracranial Hemorrhage.
Cho SM; Moazami N; Katz S; Starling R; Frontera JA
Ann Thorac Surg; 2019 Jul; 108(1):52-58. PubMed ID: 30763560
[TBL] [Abstract][Full Text] [Related]
3. Medical and Surgical Management of Left Ventricular Assist Device-Associated Intracranial Hemorrhage.
Ibeh C; Tirschwell DL; Mahr C; Creutzfeldt CJ
J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):106053. PubMed ID: 34418673
[TBL] [Abstract][Full Text] [Related]
4. Management of intracranial hemorrhage in patients with left ventricular assist devices.
Wilson TJ; Stetler WR; Al-Holou WN; Sullivan SE; Fletcher JJ
J Neurosurg; 2013 May; 118(5):1063-8. PubMed ID: 23451903
[TBL] [Abstract][Full Text] [Related]
5. Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation: A Registry Study.
Vestergaard AS; Skjøth F; Lip GY; Larsen TB
Stroke; 2016 Apr; 47(4):979-85. PubMed ID: 26883499
[TBL] [Abstract][Full Text] [Related]
6. Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation.
Nielsen PB; Larsen TB; Skjøth F; Lip GY
JAMA Intern Med; 2017 Apr; 177(4):563-570. PubMed ID: 28241151
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic therapy for left ventricular assist devices in adults: a systematic review.
Baumann Kreuziger LM; Kim B; Wieselthaler GM
J Thromb Haemost; 2015 Jun; 13(6):946-55. PubMed ID: 25845489
[TBL] [Abstract][Full Text] [Related]
8. Prothrombin Complex Concentrate for Emergent Reversal of Intracranial Hemorrhage in Patients with Ventricular Assist Devices.
Lai GY; Maas MB; Leong CR; Liotta EM; Rich JD; Pham DT; Vorovich EE; Naidech AM; Jahromi BS; Potts MB
Neurocrit Care; 2021 Oct; 35(2):506-517. PubMed ID: 33821403
[TBL] [Abstract][Full Text] [Related]
9. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage.
Witt DM; Clark NP; Martinez K; Schroeder A; Garcia D; Crowther MA; Ageno W; Dentali F; Ye X; Hylek E; Delate T
Thromb Res; 2015 Nov; 136(5):1040-4. PubMed ID: 26454758
[TBL] [Abstract][Full Text] [Related]
10. Management of Intracranial Hemorrhage in Patients with a Left Ventricular Assist Device: A Systematic Review and Meta-Analysis.
Carroll AH; Ramirez MP; Dowlati E; Mueller KB; Borazjani A; Chang JJ; Felbaum DR
J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105501. PubMed ID: 33271486
[TBL] [Abstract][Full Text] [Related]
11. Cerebrovascular Accidents During Mechanical Circulatory Support: New Predictors of Ischemic and Hemorrhagic Strokes and Outcome.
Izzy S; Rubin DB; Ahmed FS; Akbik F; Renault S; Sylvester KW; Vaitkevicius H; Smallwood JA; Givertz MM; Feske SK
Stroke; 2018 May; 49(5):1197-1203. PubMed ID: 29643259
[TBL] [Abstract][Full Text] [Related]
12. Optimal timing of resumption of warfarin after intracranial hemorrhage.
Majeed A; Kim YK; Roberts RS; Holmström M; Schulman S
Stroke; 2010 Dec; 41(12):2860-6. PubMed ID: 21030703
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support.
Saeed O; Shah A; Kargoli F; Madan S; Levin AP; Patel SR; Jermyn R; Guerrero C; Nguyen J; Sims DB; Shin J; D'Alessandro D; Goldstein DJ; Jorde UP
Circ Heart Fail; 2016 Jan; 9(1):e002296. PubMed ID: 26721914
[TBL] [Abstract][Full Text] [Related]
15. Optimal Timing for Resumption of Anticoagulation After Intracranial Hemorrhage in Patients With Mechanical Heart Valves.
Barra ME; Forman R; Long-Fazio B; Merkler AE; Gurol ME; Izzy S; Sharma R
J Am Heart Assoc; 2024 May; 13(10):e032094. PubMed ID: 38761076
[TBL] [Abstract][Full Text] [Related]
16. Intracranial Hemorrhage in Patients with Durable Mechanical Circulatory Support Devices: Institutional Review and Proposed Treatment Algorithm.
Ramey WL; Basken RL; Walter CM; Khalpey Z; Lemole GM; Dumont TM
World Neurosurg; 2017 Dec; 108():826-835. PubMed ID: 28987857
[TBL] [Abstract][Full Text] [Related]
17. Relationship Between Anticoagulation Intensity and Thrombotic or Bleeding Outcomes Among Outpatients With Continuous-Flow Left Ventricular Assist Devices.
Nassif ME; LaRue SJ; Raymer DS; Novak E; Vader JM; Ewald GA; Gage BF
Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27154497
[TBL] [Abstract][Full Text] [Related]
18. What is the optimal anticoagulation in patients with a left ventricular assist device?
Rossi M; Serraino GF; Jiritano F; Renzulli A
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):733-40. PubMed ID: 22761118
[TBL] [Abstract][Full Text] [Related]
19. Warfarin Reinitiation After Intracranial Hemorrhage: A Case Series of Heart Valve Patients.
Wan A; Butcher K; Hodgson M; Schultz K; Bungard TJ
Can J Neurol Sci; 2020 Mar; 47(2):237-241. PubMed ID: 31796141
[TBL] [Abstract][Full Text] [Related]
20. Effects of antithrombotic therapy on bleeding after endoscopic submucosal dissection.
Dong J; Wei K; Deng J; Zhou X; Huang X; Deng M; Lü M
Gastrointest Endosc; 2017 Nov; 86(5):807-816. PubMed ID: 28732709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
